ReCode Therapeutics
Alanna Manning has worked at three different institutions. Alanna began their career at Alabama State University in 2018 as an Undergraduate Researcher in the Laboratory of Dr. Derrick Dean. In 2020, they moved to the University of Toronto as a Graduate Student Researcher in the laboratory of Dr. Omar Khan. Most recently, in 2023, they began working at ReCode Therapeutics as a Research Associate II.
Alanna Manning attended Alabama State University from 2016 to 2020, and is currently pursuing a MASc in Biomedical/Medical Engineering from the University of Toronto.
ReCode Therapeutics
1 followers
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.